. home.aspx



UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

March 06, 2020 / Kate Bechtold

UroGen Pharma Ltd. a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options, today announced the grants of inducement restricted stock units (“RSUs”) to seventy-six new employees in connection with their employment with Urogen. These new team members will support the Company as it prepares for potential approval and commercial launch of its first product candidate.